FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2973258158> ?p ?o ?g. }

• W2973258158 endingPage "1561" @default.
• W2973258158 startingPage "1550" @default.
• W2973258158 abstract "Abstract Diabetes is one the most common comorbidities among people with established heart failure. Interest in heart failure as an outcome among people with diabetes has emerged since it was shown that there was an association between increased risk of hospitalization for heart failure with use of thiazolidinediones and some dipeptidyl peptidase‐4 inhibitors. Recently, sodium‐glucose co‐transporter‐2 inhibitors were shown to lead to a reduction in the risk of cardiovascular death and hospitalization for heart failure in people with Type 2 diabetes mellitus and either cardiovascular risk factors or atherosclerotic cardiovascular disease. These findings appear to be consistent in people both with and without a baseline history of heart failure. Based on current evidence there are several clinical scenarios in which the use of sodium‐glucose co‐transporter‐2 inhibitors would be justified for people with heart failure and atherosclerotic cardiovascular disease: (1) in people with a new diagnosis of Type 2 diabetes and for whom anti‐hyperglycaemic management strategies are being considered; (2) in people with sub‐optimal glycaemic control, regardless of baseline antihyperglycaemic therapy; and (3) in people with symptomatic heart failure (or other high‐risk features such as recent hospitalization for heart failure), if glycaemic control is optimized and the individual is on a sulfonylurea or dipeptidyl peptidase‐4 inhibitor; here, it may be reasonable to consider substituting one of those therapies for a sodium‐glucose co‐transporter‐2 inhibitor. There are now a number of ongoing trials evaluating the role of sodium‐glucose co‐transporter‐2 inhibitors as therapy for people with established heart failure (with preserved or with reduced ejection fraction) and regardless of the presence of diabetes. These trials will provide the evidence for the safety and efficacy of sodium‐glucose co‐transporter‐2 inhibitors among people with established heart failure." @default.
• W2973258158 created "2019-09-26" @default.
• W2973258158 creator A5020254504 @default.
• W2973258158 creator A5022314919 @default.
• W2973258158 creator A5075925255 @default.
• W2973258158 creator A5080334509 @default.
• W2973258158 creator A5080474368 @default.
• W2973258158 date "2019-10-10" @default.
• W2973258158 modified "2023-10-16" @default.
• W2973258158 title "Treatment of heart failure with sodium glucose co‐transporter‐2 inhibitors in people with type 2 diabetes mellitus: current evidence and future directions" @default.
• W2973258158 cites W1573414423 @default.
• W2973258158 cites W2064130493 @default.
• W2973258158 cites W2101382476 @default.
• W2973258158 cites W2111069331 @default.
• W2973258158 cites W2131490500 @default.
• W2973258158 cites W2145681479 @default.
• W2973258158 cites W2146264128 @default.
• W2973258158 cites W2154038775 @default.
• W2973258158 cites W2159969745 @default.
• W2973258158 cites W2273304042 @default.
• W2973258158 cites W2311523609 @default.
• W2973258158 cites W2498901811 @default.
• W2973258158 cites W2564748425 @default.
• W2973258158 cites W2579945710 @default.
• W2973258158 cites W2626446274 @default.
• W2973258158 cites W2760952310 @default.
• W2973258158 cites W2763921543 @default.
• W2973258158 cites W2772204795 @default.
• W2973258158 cites W2772844083 @default.
• W2973258158 cites W2793795908 @default.
• W2973258158 cites W2808467887 @default.
• W2973258158 cites W2884466498 @default.
• W2973258158 cites W2887650349 @default.
• W2973258158 cites W2888544493 @default.
• W2973258158 cites W2899764361 @default.
• W2973258158 cites W2899847838 @default.
• W2973258158 cites W2900413769 @default.
• W2973258158 cites W2902527999 @default.
• W2973258158 cites W2918530247 @default.
• W2973258158 cites W2921779932 @default.
• W2973258158 cites W2921866736 @default.
• W2973258158 cites W2923389432 @default.
• W2973258158 cites W2936593438 @default.
• W2973258158 cites W2941293571 @default.
• W2973258158 cites W2965056983 @default.
• W2973258158 cites W2974260792 @default.
• W2973258158 cites W4252437054 @default.
• W2973258158 doi "https://doi.org/10.1111/dme.14140" @default.
• W2973258158 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31536660" @default.
• W2973258158 hasPublicationYear "2019" @default.
• W2973258158 type Work @default.
• W2973258158 sameAs 2973258158 @default.
• W2973258158 citedByCount "3" @default.
• W2973258158 countsByYear W29732581582020 @default.
• W2973258158 countsByYear W29732581582021 @default.
• W2973258158 countsByYear W29732581582023 @default.
• W2973258158 crossrefType "journal-article" @default.
• W2973258158 hasAuthorship W2973258158A5020254504 @default.
• W2973258158 hasAuthorship W2973258158A5022314919 @default.
• W2973258158 hasAuthorship W2973258158A5075925255 @default.
• W2973258158 hasAuthorship W2973258158A5080334509 @default.
• W2973258158 hasAuthorship W2973258158A5080474368 @default.
• W2973258158 hasConcept C126322002 @default.
• W2973258158 hasConcept C134018914 @default.
• W2973258158 hasConcept C164705383 @default.
• W2973258158 hasConcept C2777180221 @default.
• W2973258158 hasConcept C2778198053 @default.
• W2973258158 hasConcept C2910068830 @default.
• W2973258158 hasConcept C555293320 @default.
• W2973258158 hasConcept C71924100 @default.
• W2973258158 hasConceptScore W2973258158C126322002 @default.
• W2973258158 hasConceptScore W2973258158C134018914 @default.
• W2973258158 hasConceptScore W2973258158C164705383 @default.
• W2973258158 hasConceptScore W2973258158C2777180221 @default.
• W2973258158 hasConceptScore W2973258158C2778198053 @default.
• W2973258158 hasConceptScore W2973258158C2910068830 @default.
• W2973258158 hasConceptScore W2973258158C555293320 @default.
• W2973258158 hasConceptScore W2973258158C71924100 @default.
• W2973258158 hasIssue "12" @default.
• W2973258158 hasLocation W29732581581 @default.
• W2973258158 hasLocation W29732581582 @default.
• W2973258158 hasOpenAccess W2973258158 @default.
• W2973258158 hasPrimaryLocation W29732581581 @default.
• W2973258158 hasRelatedWork W1531601525 @default.
• W2973258158 hasRelatedWork W2758277628 @default.
• W2973258158 hasRelatedWork W2887313104 @default.
• W2973258158 hasRelatedWork W2935909890 @default.
• W2973258158 hasRelatedWork W2948807893 @default.
• W2973258158 hasRelatedWork W3173606202 @default.
• W2973258158 hasRelatedWork W3183948672 @default.
• W2973258158 hasRelatedWork W4387497383 @default.
• W2973258158 hasRelatedWork W2778153218 @default.
• W2973258158 hasRelatedWork W3110381201 @default.
• W2973258158 hasVolume "36" @default.
• W2973258158 isParatext "false" @default.
• W2973258158 isRetracted "false" @default.
• W2973258158 magId "2973258158" @default.
• W2973258158 workType "article" @default.